New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers Will Be Presented at the 2025 ASCO GU Symposium.

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

Are you interested in receiving a Prevent Cancer Foundation research grant? Applications for 2026 grants will open in the ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, announced today that it has closed on a $600 million senior secured revolving credit facility with a bank ...

As the authors note, prostate MRI and tissue-based gene expression tests improve local staging and estimates ... In this real-world study conducted at the national scale, Decipher genomic classifier ...

Robot Corp. , a leader in consumer robots, today announced that the company will host its fourth-quarter and full-year 2024 earnings conference call on Wednesday, March 12. Prior to the call, iRobot ...

Danelle Scalia never imagined that she would be fighting for her life against ovarian cancer at the age of just 41.But her ...

Cancer misinformation spreads farther and faster than accurate information on social media, through public posts, by word of mouth, and private messages. This harmful content includes claims that are ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...